中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
1期
185-186
,共2页
徐卫波%侯俊清%刘广超%杜信毅%李铁强%朱朝阳
徐衛波%侯俊清%劉廣超%杜信毅%李鐵彊%硃朝暘
서위파%후준청%류엄초%두신의%리철강%주조양
膀胱移行细胞癌%细胞核增殖抗原%E-钙黏蛋白
膀胱移行細胞癌%細胞覈增殖抗原%E-鈣黏蛋白
방광이행세포암%세포핵증식항원%E-개점단백
Bladder transitional cell carcinoma%Proliferation cell nuclear antigen%E-cadherin
目的 探讨细胞核增殖抗原(Ki-67)、E-钙黏蛋白(E-cadherin)在膀胱移行细胞癌中的表达及其临床意义.方法 采用免疫组织化学方法检测Ki-67、E-cadherin在48例膀胱移行细胞癌组织中的表达,统计分析其表达与膀胱移行细胞癌临床病理、分期之间的关系.结果 Ki-67、E-cadherin在膀胱移行细胞癌中的阳性表达率分别是83.3%和47.9%,两者呈负相关(P<0.05).两者表达水平与肿瘤临床分期及病理分级明显相关(P<0.05).结论 检测Ki-67与E-cadherin有助于判断膀胱移行细胞癌侵袭和转移能力.
目的 探討細胞覈增殖抗原(Ki-67)、E-鈣黏蛋白(E-cadherin)在膀胱移行細胞癌中的錶達及其臨床意義.方法 採用免疫組織化學方法檢測Ki-67、E-cadherin在48例膀胱移行細胞癌組織中的錶達,統計分析其錶達與膀胱移行細胞癌臨床病理、分期之間的關繫.結果 Ki-67、E-cadherin在膀胱移行細胞癌中的暘性錶達率分彆是83.3%和47.9%,兩者呈負相關(P<0.05).兩者錶達水平與腫瘤臨床分期及病理分級明顯相關(P<0.05).結論 檢測Ki-67與E-cadherin有助于判斷膀胱移行細胞癌侵襲和轉移能力.
목적 탐토세포핵증식항원(Ki-67)、E-개점단백(E-cadherin)재방광이행세포암중적표체급기림상의의.방법 채용면역조직화학방법검측Ki-67、E-cadherin재48례방광이행세포암조직중적표체,통계분석기표체여방광이행세포암림상병리、분기지간적관계.결과 Ki-67、E-cadherin재방광이행세포암중적양성표체솔분별시83.3%화47.9%,량자정부상관(P<0.05).량자표체수평여종류림상분기급병리분급명현상관(P<0.05).결론 검측Ki-67여E-cadherin유조우판단방광이행세포암침습화전이능력.
Objective To explore the clinical significance and expression of proliferation cell nuclear antigen (Ki-67) and E-cadherin in bladder transitional cell carcinoma.Methods Immunohistochemistry was applied to detect the expression of Ki-67 and E-cadherin in 48 cases of bladder transitional cell carcinoma,and the relationship between their expression and clinicopathological features was analyzed.Results The expression of Ki-67 and E-cadherin was negatively correlated (P < 0.05),and their positive rate was 83.3% and 47.9% respectively.They were related to tumor pathological grade and clinical stage.Conclusion Detection of Ki-67 and E-cadherin will help determine the invasion and metastasis ability of bladder transitional cell carcinoma.